Pharmacotherapy Risks in Rare Genetic Diseases: Cross-Referencing ACMG Secondary Findings v3.2 List With Clinical Databases. [PDF]
Allen JD, Duong BQ, Brady J, Arn P.
europepmc +1 more source
Cardiovascular adverse effects of common non-oncologic medications: from mechanisms to clinical management. [PDF]
Bahit MC +3 more
europepmc +1 more source
Biased Orthosteric Agonism and Allosteric Modulation: Emerging Strategies for Developing New Class of β-Agonists for Obstructive Airway Diseases. [PDF]
Shah SD, Deshpande DA.
europepmc +1 more source
Vitamin A Derivatives and Adipose Tissue Differentiation: Molecular Pathways Driving Browning and Anti-Obesity Effects. [PDF]
Bilikozen Aygun B, Basturk B, Ayaz A.
europepmc +1 more source
Mechanism of amylase release by .ALPHA.-adrenergic and cholinergic agonists in rat parotid gland.
Eriko NEZU
openalex +2 more sources
Pharmacological Interventions for Orthostatic Hypotension: A Systematic Review. [PDF]
Verma A +6 more
europepmc +1 more source
Effects of the alpha 2‐adrenergic agonist clonidine and its antagonist idazoxan on the fetal lamb.
O. S. Bamford +3 more
openalex +1 more source
Multicomplex Pharmacophore Modeling of Estrogen Receptors Suggests the Probable Repurposing of Procaterol as an Antiproliferative Agent Against Breast Cancer Cells. [PDF]
Vazquez-Mendoza LH +6 more
europepmc +1 more source

